Remove Acquisitions Remove Economics Remove Pharmaceutical
article thumbnail

Mergers and Acquisitions in the Age of Trump: Opportunities and Challenges

MergersCorp M&A International

The election of Donald Trump as President of the United States in November 2024 marked a significant change in the political and economic landscape of the country. His presidency brought with it a unique set of policies and attitudes that would directly influence the realm of mergers and acquisitions (M&A).

article thumbnail

Cooley’s 2024 Life Sciences M&A Year in Review: M&A Slims Down in 2024, but Will Appetites Grow in 2025?

Cooley M&A

While global M&A deal value across sectors remained relatively flat overall , pharmaceuticals and life sciences M&A in 2024 dipped relative to the prior year. Indeed, the largest US biotech exit in 2024 was Vertex Pharmaceuticals $4.9 Total deal value is where the market really shed its weight down a remarkable 33.7%

M&A
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UBS likes these defensive plays – which also happen to offer solid dividends

CNBC: Investing

In a June 6 report, UBS global equity strategist Andrew Garthwaite gave several reasons why his team is cautious on many cyclical names – that is, stocks whose performance is closely tied to the economic cycle – excluding financials. Last month, the Gatorade maker completed its acquisition of probiotic soda brand Poppi for $1.95

S&P
article thumbnail

PODCAST REVIEW: ACQUIRING MINDS: How to Buy the Business Where You Work | Corey Veverka Interview

How2Exit

rn About The Guest(s): Corey Veverka is the owner of TBS, a company that specializes in validation and compliance for pharmaceutical manufacturing facilities. He emphasizes the importance of building a team of professionals to guide the acquisition process and shares his experience with refinancing the SBA loan.

article thumbnail

Managing Product Shortages through Strategic M&A: Building a Resilient Supply Chain

Sun Acquisitions

These shortages can result from various factors, including natural disasters, geopolitical tensions, economic instability, and unexpected surges in demand. To mitigate these risks and build more resilient supply chains, companies are increasingly turning to strategic mergers and acquisitions (M&A).

M&A
article thumbnail

Factors impacting Perpetual Growth Rate in a DCF

Wizenius

Macroeconomic Factors: The global economic landscape can significantly impact growth rates. Pharmaceutical Sector: In the pharmaceutical industry, growth rates can be influenced by factors like patent expirations, drug pipelines, and regulatory approvals.

DCF
article thumbnail

The Education Technology (EdTech) Industry: Overview of Mergers, Acquisitions and Venture Capital Trends & Investments

InvestmentBank.com

The benefits of VR are not limited to language immersion, architecture, interior design, space expedition, biology, chemistry or pharmaceutical practices. They also have developed Daydream Labs where employees can be trained visually and interactively, resulting in a faster learning process [9].